DA2 Ubiquitin Ligase Modulation for Larger Seeds and Organs
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The genetic mechanisms controlling seed and organ size in plants are not fully understood, limiting the ability to enhance crop yield and plant biomass effectively.
Innovation Solution
The identification of a plant E3 ubiquitin ligase, DA2, which regulates seed and organ size by restricting cell proliferation, allows for methods to increase yield by reducing its expression or activity in combination with DA1 and/or EOD1, either through genetic modification or by overexpressing dominant-negative forms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Volume of stationary object
If the expression or activity of DA2 is reduced in plants deficient in DA1 or EOD1, then seed and organ size is enhanced synergistically, but the complexity of genetic modification increases
Solution Approach 1:
The invention segments the size control mechanism into multiple independent genetic components (DA1, EOD1, and DA2) that can be individually modified. By targeting DA2 expression reduction in combination with DA1 or EOD1 deficiency, the patent achieves synergistic enhancement of seed and organ size through modular genetic alterations rather than attempting to modify a single complex pathway.
Solution Approach 2:
The invention changes the expression parameter of DA2 by reducing its activity or expression levels in plants that are already deficient in DA1 or EOD1. This parameter modification approach allows precise control over cell proliferation restriction, thereby synergistically enhancing seed and organ size without requiring complete genetic overhaul of the plant system.
2Productivity
If DA2 expression is reduced to increase yield, then productivity improves, but understanding of genetic mechanisms remains incomplete
Solution Approach 1:
The invention performs preliminary genetic modifications by first establishing plants deficient in DA1 or EOD1, then subsequently reducing DA2 expression in these modified plants. This stepwise preliminary action allows researchers to observe synergistic effects on seed and organ size while systematically building understanding of the genetic mechanisms involved in size control.
Solution Approach 2:
The invention uses DA2 as an intermediary target to connect and study the functional relationships between DA1/EOD1 pathways and seed/organ size control. By reducing DA2 expression in plants deficient in DA1 or EOD1, the patent creates a system that mediates the interaction between these genetic factors, allowing indirect investigation of genetic mechanisms while achieving yield improvement.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach synergistically enhances seed and organ size, leading to increased plant yield and biomass.
Implementation Method 1
DA2 is a plant E3 ubiquitin ligase which regulates the final size of seeds and organs by restricting cell proliferation
Data Source
Figure 1A~1E
Figure 2F~2G
Figure 3A~3D
AI summary
This invention relates to a plant E3 ubiquitin ligase (termed DA2) which acts synergistically with DA1 to control seed and organ size. Methods of increasing plant yield are provided that comprise reducing the expression or activity of DA2 in a plant that is deficient in DA1 expression or activity. Plants with increased yield and methods of producing such plants are also provided.